The North America Magnetoencephalography Market would witness market growth of 4.6% CAGR during the forecast period (2022-2028).
Magnetoencephalography gives researchers a tool that is entirely noninvasive with which to investigate the human brain's real-time functioning under experimental conditions suited to the investigation of sensory and cognitive brain functions in addition to the disruptions that can occur in these functions.
When considering the potential role that MEG will play in the future of cognitive brain research, it is vital to keep in mind that MEG and EEG are the only noninvasive methods that can provide accurate temporal information about the patterns of brain activation that occur in response to the external environment. In addition, when comparing these two methods, MEG locates sources with a far higher degree of precision.
Although there is a possibility that MEG might be more 'patient-friendly' than EEG because it does not involve the implantation of electrodes on the scalp, the much higher cost of MEG has mainly prevented its usage in everyday settings. Instead, MEG has been used primarily for one purpose: to pinpoint the origin of evoked potentials and localized epileptiform activity. This is often done to use the technique in epilepsy surgery.
As of 2014, there were approximately 6 million senior citizens living in Canada, making up about 15.6 percent of the country's total population. In Canada, the number of people aged 65 and older is expected to surpass 9.5 million by the year 2030, which is less than 20 years away. This age group has a significantly increased chance of developing neurological diseases. As a result of the increased prevalence of neurological illnesses throughout the region's countries, there will be an increased need for magnetoencephalography, which will support market growth.
The US market dominated the North America Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $88,192.6 Thousands by 2028. The Canada market is experiencing a CAGR of 6.9% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 6% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
Magnetoencephalography gives researchers a tool that is entirely noninvasive with which to investigate the human brain's real-time functioning under experimental conditions suited to the investigation of sensory and cognitive brain functions in addition to the disruptions that can occur in these functions.
When considering the potential role that MEG will play in the future of cognitive brain research, it is vital to keep in mind that MEG and EEG are the only noninvasive methods that can provide accurate temporal information about the patterns of brain activation that occur in response to the external environment. In addition, when comparing these two methods, MEG locates sources with a far higher degree of precision.
Although there is a possibility that MEG might be more 'patient-friendly' than EEG because it does not involve the implantation of electrodes on the scalp, the much higher cost of MEG has mainly prevented its usage in everyday settings. Instead, MEG has been used primarily for one purpose: to pinpoint the origin of evoked potentials and localized epileptiform activity. This is often done to use the technique in epilepsy surgery.
As of 2014, there were approximately 6 million senior citizens living in Canada, making up about 15.6 percent of the country's total population. In Canada, the number of people aged 65 and older is expected to surpass 9.5 million by the year 2030, which is less than 20 years away. This age group has a significantly increased chance of developing neurological diseases. As a result of the increased prevalence of neurological illnesses throughout the region's countries, there will be an increased need for magnetoencephalography, which will support market growth.
The US market dominated the North America Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $88,192.6 Thousands by 2028. The Canada market is experiencing a CAGR of 6.9% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 6% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
Scope of the Study
Market Segments Covered in the Report:
By Application
- Clinical
- Epilepsy
- Dementia
- Autism
- Stroke
- Multiple Sclerosis
- Schizophrenia
- Others
- Research
By End-use
- Hospitals
- Academic & Research Institutes
- Imaging centres
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc
- MEGIN OY
- CTF MEG Neuro Innovations, Inc
- Cerca Magnetics Limited
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Magnetoencephalography Market, by Application
1.4.2 North America Magnetoencephalography Market, by End-use
1.4.3 North America Magnetoencephalography Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Magnetoencephalography Market by Application
3.1 North America Clinical Market by Country
3.2 North America Magnetoencephalography Market by Clinical Type
3.2.1 North America Epilepsy Market by Country
3.2.2 North America Dementia Market by Country
3.2.3 North America Autism Market by Country
3.2.4 North America Stroke Market by Country
3.2.5 North America Multiple Sclerosis Market by Country
3.2.6 North America Schizophrenia Market by Country
3.2.7 North America Others Market by Country
3.3 North America Research Market by Country
Chapter 4. North America Magnetoencephalography Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Academic & Research Institutes Market by Country
4.3 North America Imaging centres Market by Country
Chapter 5. North America Magnetoencephalography Market by Country
5.1 US Magnetoencephalography Market
5.1.1 US Magnetoencephalography Market by Application
5.1.1.1 US Magnetoencephalography Market by Clinical Type
5.1.2 US Magnetoencephalography Market by End-use
5.2 Canada Magnetoencephalography Market
5.2.1 Canada Magnetoencephalography Market by Application
5.2.1.1 Canada Magnetoencephalography Market by Clinical Type
5.2.2 Canada Magnetoencephalography Market by End-use
5.3 Mexico Magnetoencephalography Market
5.3.1 Mexico Magnetoencephalography Market by Application
5.3.1.1 Mexico Magnetoencephalography Market by Clinical Type
5.3.2 Mexico Magnetoencephalography Market by End-use
5.4 Rest of North America Magnetoencephalography Market
5.4.1 Rest of North America Magnetoencephalography Market by Application
5.4.1.1 Rest of North America Magnetoencephalography Market by Clinical Type
5.4.2 Rest of North America Magnetoencephalography Market by End-use
Chapter 6. Company Profiles
6.1 Compumedics Limited
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Partnerships, Collaborations and Agreements:
6.2 Ricoh Company, Ltd
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 FieldLine, Inc.
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Product Launches and Product Expansions:
6.4 MEGIN OY
6.4.1 Company Overview
6.5 CTF MEG Neuro Innovations, Inc.
6.5.1 Company Overview
6.6 Cerca Magnetics Limited
6.6.1 Company Overview
Companies Mentioned
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc.
- MEGIN OY
- CTF MEG Neuro Innovations, Inc.
- Cerca Magnetics Limited
Methodology
LOADING...
